ATE170868T1 - Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen - Google Patents

Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen

Info

Publication number
ATE170868T1
ATE170868T1 AT94201570T AT94201570T ATE170868T1 AT E170868 T1 ATE170868 T1 AT E170868T1 AT 94201570 T AT94201570 T AT 94201570T AT 94201570 T AT94201570 T AT 94201570T AT E170868 T1 ATE170868 T1 AT E170868T1
Authority
AT
Austria
Prior art keywords
beta
interleukin
peptide
inhibitors
converting enzymes
Prior art date
Application number
AT94201570T
Other languages
English (en)
Inventor
Roland E Dolle
Jasbir Singh
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Application granted granted Critical
Publication of ATE170868T1 publication Critical patent/ATE170868T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
    • C07F9/32Esters thereof
    • C07F9/3258Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3264Esters with hydroxyalkyl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075Esters with hydroxyalkyl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/48Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof
    • C07F9/4866Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof the ester moiety containing a substituent or structure which is considered as characteristic
AT94201570T 1993-06-04 1994-06-02 Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen ATE170868T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7321993A 1993-06-04 1993-06-04

Publications (1)

Publication Number Publication Date
ATE170868T1 true ATE170868T1 (de) 1998-09-15

Family

ID=22112457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94201570T ATE170868T1 (de) 1993-06-04 1994-06-02 Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen

Country Status (15)

Country Link
EP (1) EP0644197B1 (de)
JP (1) JPH0725887A (de)
KR (1) KR950000717A (de)
AT (1) ATE170868T1 (de)
AU (1) AU685447B2 (de)
CA (1) CA2125080A1 (de)
CZ (1) CZ137994A3 (de)
DE (1) DE69413167T2 (de)
DK (1) DK0644197T3 (de)
ES (1) ES2122145T3 (de)
FI (1) FI942625A (de)
IL (1) IL109901A (de)
NO (1) NO304983B1 (de)
NZ (1) NZ260675A (de)
SK (1) SK68694A3 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874424A (en) * 1995-12-20 1999-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US6008217A (en) * 1995-12-20 1999-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5847135A (en) * 1994-06-17 1998-12-08 Vertex Pharmaceuticals, Incorporated Inhibitors of interleukin-1β converting enzyme
US5716929A (en) * 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US5756466A (en) * 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US6420522B1 (en) 1995-06-05 2002-07-16 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
AU5122196A (en) * 1995-03-31 1996-10-16 Takeda Chemical Industries Ltd. Cysteine protease inhibitor
EP1389624A1 (de) * 1995-07-17 2004-02-18 Cephalon, Inc. Phosphor enthaltende Hemmer von Cystein- und Serin-Proteasen
ES2210377T3 (es) * 1995-07-17 2004-07-01 Cephalon, Inc. Inhibidores de cisteina y serina proteasa que contienen fosforo.
US5639732A (en) * 1996-07-10 1997-06-17 Cephalon, Inc. Phosphorous-containing cysteine and serine protease inhibitors
US5843904A (en) * 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
EP0914333B1 (de) 1996-06-07 2004-11-24 AstraZeneca AB Peptid derivate
GB9621836D0 (en) 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
DE69925581T2 (de) 1998-03-09 2006-04-27 Vertex Pharmaceuticals Inc., Cambridge 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
DK1064298T3 (da) 1998-03-19 2009-01-19 Vertex Pharma Inhibitorer af caspaser
WO1999064434A1 (en) 1998-06-11 1999-12-16 Isis Pharmaceuticals, Inc. Synthetic methods and intermediates for triester oligonucleotides
US6242422B1 (en) 1998-10-22 2001-06-05 Idun Pharmacueticals, Inc. (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
US7157430B2 (en) 1998-10-22 2007-01-02 Idun Pharmaceuticals, Inc. (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
US6525024B1 (en) 2000-04-17 2003-02-25 Idun Pharmaceuticals, Inc. Inhibitors of the ICE/ced-3 family of cysteine proteases
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
KR100448008B1 (ko) 2002-07-20 2004-09-08 주식회사 효성 고강도 저수축 폴리에스테르 섬유 및 그 제조방법
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
EP2295054A1 (de) 2004-05-27 2011-03-16 Vertex Pharmaceuticals Incorporated Ice-hemmer zur Behandlung von autoinflammatorischen Erkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133354T2 (de) * 1991-08-30 2004-11-11 Vertex Pharmaceuticals Inc., Cambridge Interleukin 1-beta protease und ihre inhibitoren
GB9123326D0 (en) * 1991-11-04 1991-12-18 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EP0644197B1 (de) 1998-09-09
FI942625A (fi) 1994-12-05
JPH0725887A (ja) 1995-01-27
EP0644197A1 (de) 1995-03-22
DK0644197T3 (da) 1999-06-07
CA2125080A1 (en) 1994-12-05
SK68694A3 (en) 1995-02-08
DE69413167D1 (de) 1998-10-15
AU685447B2 (en) 1998-01-22
NO304983B1 (no) 1999-03-15
ES2122145T3 (es) 1998-12-16
FI942625A0 (fi) 1994-06-03
NZ260675A (en) 1996-04-26
KR950000717A (ko) 1995-01-03
DE69413167T2 (de) 1999-05-06
AU6451494A (en) 1994-12-08
IL109901A (en) 1999-06-20
IL109901A0 (en) 1994-10-07
CZ137994A3 (en) 1995-06-14
NO942065D0 (no) 1994-06-03
NO942065L (no) 1994-12-05

Similar Documents

Publication Publication Date Title
ATE170868T1 (de) Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen
NO942064L (no) yminhibitorer
DK0966465T3 (da) Inhibitorer af IMPDH-enzymer
DK0764167T3 (da) Bicyclisk lactamhæmmer af interleukin-1-beta-omdannende enzym
TR199801168T2 (xx) �nterleukin-1 beta d�n��t�r�c� enzim inhibit�rleri.
FI942423A0 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
ATE226193T1 (de) Substituierte zyklische amine als metalloproteaseinhibitoren
DE69232929D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
MX9703564A (es) Inhibidores de proteasa multicatalitica.
BG104780A (en) Inhibitors of phospholipase enzymes
TR199802136T2 (xx) �MPDH enzimi inhibit�rleri olarak �re t�revleri.
ATE335813T1 (de) Protease varianten
NO983688L (no) Serin-protease-inhibitorer
YU34393A (sh) Novi 7 beta-supstituisani-4-aza-5alfa-holestanoni kao inhibitori 5alfa-reduktaze
ATE153670T1 (de) Peptidboronsäurederivate mit protease inhibierenden aktivität
NO943765L (no) Aryloksybenzen-herbicidmidler
ES2173634T3 (es) Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.
DE59905355D1 (de) Verwendung von katecholderivaten als proteinaseinhibitoren
NO970498L (no) Benzimidazolderivater med dopaminergisk aktivitet

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee